AI Insights · Timothy · July 2023
Top 5 Medical Apps on iOS in South America in Q2 2023
Explore the performance of the top 5 medical apps on iOS in South America during Q2 2023, highlighting trends in downloads, revenue, and active users.
In Q2 2023, the top 5 medical apps on the iOS platform in South America exhibited notable trends in downloads, revenue, and active users. The data, sourced from Sensor Tower, provides valuable insights into the market dynamics and user engagement for these applications.
Afya Whitebook: App Medicina from AFYA PARTICIPACOES S.A. showed a relatively stable weekly revenue, peaking at approximately $70K in the week of March 27 and ending the quarter with around $62K in the week of June 26. Weekly downloads fluctuated, with the highest at 2K in the week of March 27 and the lowest at 985 in the week of June 5. The app's weekly active users remained fairly consistent, ending the quarter with 19.2K users.
WeMeds demonstrated a steady increase in weekly revenue, starting at $4.5K in the week of March 27 and peaking at $7.4K in the week of June 19. Downloads saw a peak of 2.1K in the week of May 15 but dropped to 950 in the week of June 19.
Sanford Guide from Antimicrobial Therapy, Inc. maintained a stable revenue stream, starting at $5.4K in the week of March 27 and peaking at $6.7K in the week of April 24. Weekly downloads were relatively low, with the highest being 249 in the week of April 10. Active users showed a gradual increase, peaking at 1.4K in the week of April 17.
MEDCode – App medicina from TEDMED Tecnologia de Ensino a Distancia em Medicina LTDA ME had a more volatile revenue performance, with a peak of $5.9K in the week of June 5. Downloads remained low, peaking at 285 in the week of March 27.
+PSI - Psicofármacos, DSM, CID from Grupo A showed an increasing trend in revenue, starting at $2.1K in the week of March 27 and reaching $3.7K in the week of June 26. Downloads were modest, peaking at 143 in the week of April 10.
For more detailed insights and trends, visit Sensor Tower.